<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9961">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01964105</url>
  </required_header>
  <id_info>
    <org_study_id>201210065</org_study_id>
    <nct_id>NCT01964105</nct_id>
  </id_info>
  <brief_title>3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery</brief_title>
  <official_title>3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery: Does 3D Improve Patient Reported Outcomes in Primary Breast Augmentation?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to evaluate the impact of incorporating three-dimensional
      (3D)imaging during preoperative consultation on patient reported outcomes in primary breast
      augmentation surgery.  3D imaging is an innovative technology that allows the surgeon to
      share with images how one could look after one's procedure. The patient's assessment will
      be collected using the Breast Q, an objective questionnaire that captures patient
      satisfaction with breast augmentation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Breast Q Augmentation Module</measure>
    <time_frame>up to 6 months postop visit.</time_frame>
    <safety_issue>No</safety_issue>
    <description>This module has 6 core items.  Three of these items are recently shown to statistically significantly improve in patients undergoing breast augmentation: 1) satisfaction with breasts, 2) psychological well-being, 3) sexual well-being.  The remaining core items: 4) satisfaction with care, 5) physical well-being, and 6) satisfaction with overall outcome will also be recorded. Estimated start of Breast Q complete data analysis is September 2015.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hypomastia</condition>
  <condition>Primary Breast Augmentation</condition>
  <arm_group>
    <arm_group_label>3D Imaging Simulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Group:  3D Image Simulation + Standard Preoperative Evaluation Goal:  50 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Preoperative Evaluation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Group: Patients will receive standard preoperative evaluation (2D imaging).
Goal:  50 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Randomized Cohort:  3D Imaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who refuse the option of randomization but otherwise meet the inclusion and exclusion criteria will be offered participation in this study as part of a non-randomized cohort.
Goal:  50 Patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D Imaging</intervention_name>
    <arm_group_label>3D Imaging Simulation</arm_group_label>
    <arm_group_label>Non-Randomized Cohort:  3D Imaging</arm_group_label>
    <other_name>Vectra 3D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Scheduled for elective breast augmentation cosmetic procedure.

        Exclusion Criteria:

          -  Breast reconstruction for malignancy

          -  Cognitively unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terence M Myckatyn, MD, FACS, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colleen Kilbourne, MA</last_name>
    <phone>314-996-3873</phone>
    <email>kilbournec@wudosis.wustl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>West County Plastic Surgeons of Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Terence M Myckatyn, MD, FACS, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marissa J Tenenbaum, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://westcountyplasticsurgeons.wustl.edu/</url>
    <description>Click here for Washington University's study location.</description>
  </link>
  <reference>
    <citation>Tepper OM, Unger JG, Small KH, Feldman D, Kumar N, Choi M, Karp NS. Mammometrics: the standardization of aesthetic and reconstructive breast surgery. Plast Reconstr Surg. 2010 Jan;125(1):393-400. doi: 10.1097/PRS.0b013e3181c4966e.</citation>
    <PMID>20048631</PMID>
  </reference>
  <reference>
    <citation>Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-53. doi: 10.1097/PRS.0b013e3181aee807. PubMed PMID: 19644246.</citation>
    <PMID>19644246</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 16, 2013</lastchanged_date>
  <firstreceived_date>September 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypomastia</keyword>
  <keyword>Augmentation</keyword>
  <keyword>Breast</keyword>
  <keyword>3D</keyword>
  <keyword>Breast Q</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
